Optimizing Aggregated N-Of-1 Trial Designs for Predictive Biomarker Validation: Statistical Methods and Theoretical Findings (original) (raw)
Randomized Clinical Trials With Biomarkers: Design Issues
Lisa McShane
JNCI Journal of the National Cancer Institute, 2010
View PDFchevron_right
Randomized Phase II Trial Designs With Biomarkers
Lisa McShane
Journal of Clinical Oncology, 2012
View PDFchevron_right
Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All
Daniel Sargent
Journal of Biopharmaceutical Statistics, 2009
View PDFchevron_right
Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
R. Kolamunnage-Dona
Journal of personalized medicine, 2017
View PDFchevron_right
Improving clinical trial efficiency by biomarker-guided patient selection
Kit Roes
Trials, 2014
View PDFchevron_right
Evaluation of biomarkers for treatment selection using individual participant data from multiple clinical trials
Corine Koopmans
Statistics in medicine, 2018
View PDFchevron_right
Designing a Randomized Clinical Trial to Evaluate Personalized Medicine: A New Approach Based on Risk Prediction
Daniel Sargent
JNCI Journal of the National Cancer Institute, 2010
View PDFchevron_right
Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint
Stefan Michiels
Statistics in medicine, 2011
View PDFchevron_right
Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials
Scott Zeger
Controlled Clinical Trials, 2001
View PDFchevron_right
Design of Early Validation Trials of Biomarkers
Daniel Normolle
Cancer informatics
View PDFchevron_right
Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
Lisa McShane
JNCI Journal of the National Cancer Institute, 2013
View PDFchevron_right
Statistical Considerations for the Next Generation of Clinical Trials
Daniel Sargent
Seminars in Oncology, 2011
View PDFchevron_right
Evaluations and Comparisons of Treatment Effects Based on Best Combinations of Biomarkers with Applications to Biomedical Studies
Albert Vexler
Journal of Computational Biology, 2014
View PDFchevron_right
Sequential Allocation and Balancing Prognostic Factors in a Psychiatric Clinical Trial
Juliana Diniz
Nature Precedings
View PDFchevron_right
Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example
Lissette Saavedra
Journal of Substance Abuse Treatment, 2015
View PDFchevron_right
Why and How Should We Integrate Biomarkers into Complex Trials? A Discussion on Paradigms and Clinical Research Strategies
Scott Mist
Complementary Medicine Research, 2019
View PDFchevron_right
Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressants
Alan Wade
Journal of Psychiatric Research, 2014
View PDFchevron_right
Biomarker-Driven Oncology Trial Design and Subgroup Characterization: Challenges and Potential Solutions
Yannan Nancy Dou, Binbing Yu, jacques mascaro
JCO Precision Oncology, 2024
View PDFchevron_right
Publication and non-publication of clinical trials in PTSD: an overview
Leigh van den Heuvel
Research Integrity and Peer Review
View PDFchevron_right
Threats to the validity of clinical trials employing enrichment strategies for sample selection
Paul Leber
Controlled clinical trials, 1998
View PDFchevron_right
Innovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy
Eliana Tossani
Progress in neuro-psychopharmacology & biological psychiatry, 2013
View PDFchevron_right
University of Pennsylvania seventh annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (morning panel discussion)
Herbert Weisberg
Clinical trials (London, England), 2015
View PDFchevron_right
The comparison of designs for sequential clinical trials with covariate information
Anthony Atkinson
Journal of the Royal Statistical Society: Series A (Statistics in Society), 2002
View PDFchevron_right
Sample size determination and treatment screening in two-stage phase II clinical trials via ROC curve
Yuan-chin Chang
Pharmaceutical Statistics, 2018
View PDFchevron_right
Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies
Pei He
British medical bulletin, 2015
View PDFchevron_right
Biomarker-guided trials: Challenges in practice
R. Kolamunnage-Dona
Contemporary Clinical Trials Communications, 2019
View PDFchevron_right
Using biological markers to inform a clinically meaningful treatment response
Linda Bierer
Annals of The New York Academy of Sciences, 2010
View PDFchevron_right
The changing perspective of clinical trial designs
Sunny Singhal
Perspectives in Clinical Research, 2021
View PDFchevron_right
Identifying Differential Responders and Their Characteristics in Clinical Trials: Innovative Methods for Analyzing Longitudinal Data
Donald Stull
Value in Health, 2013
View PDFchevron_right
Planning clinically relevant biomarker validation studies using the " number needed to treat " concept
Roger Day
View PDFchevron_right
Cutoff assignment strategies for enhancing randomized clinical trials
Joseph Cappelleri
Controlled Clinical Trials, 1992
View PDFchevron_right
A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial
Christian Webb
Psychotherapy and psychosomatics, 2018
View PDFchevron_right
Augmented trial designs for evaluation of principal surrogates
Dean Follmann
Biostatistics, 2016
View PDFchevron_right
Meeting the demand for more sophisticated study designs. A proposal for a new type of clinical trial: The hybrid design
Haitao Chu
2011
View PDFchevron_right
Meeting abstracts from the 5th International Clinical Trials Methodology Conference (ICTMC 2019)
Gillian Shorter
Trials, 2019
View PDFchevron_right